Matches in Nanopublications for { ?s ?p "[ZQNK-29 is a well characterized premature human NK/T-cell lymphoma cell line with expression of the B-cell marker CD20 and will provide a useful pre-clinic model for characterization and potential therapeutic studies of the aggressive NK/T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1293071.RAXzyQ-Fc7iQ9WKG9j9_HycDmkw6NNRcbXQwy0yiOipuM130_assertion description "[ZQNK-29 is a well characterized premature human NK/T-cell lymphoma cell line with expression of the B-cell marker CD20 and will provide a useful pre-clinic model for characterization and potential therapeutic studies of the aggressive NK/T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293071.RAXzyQ-Fc7iQ9WKG9j9_HycDmkw6NNRcbXQwy0yiOipuM130_provenance.
- NP1293073.RAxQfGulaihXX9DMt2vf9YgNbF3I1ALhN1m9Kj9SI84dI130_assertion description "[ZQNK-29 is a well characterized premature human NK/T-cell lymphoma cell line with expression of the B-cell marker CD20 and will provide a useful pre-clinic model for characterization and potential therapeutic studies of the aggressive NK/T-cell lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293073.RAxQfGulaihXX9DMt2vf9YgNbF3I1ALhN1m9Kj9SI84dI130_provenance.